Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
16.76
+0.40 (2.44%)
At close: Apr 8, 2026, 4:00 PM EDT
16.76
0.00 (0.00%)
After-hours: Apr 8, 2026, 4:20 PM EDT
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $826.54 million as of April 8, 2026.
Market Cap
826.54M
Enterprise Value
491.23M
1-Year Change
n/a
Ranking
Category
Stock Price
$16.76
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $826.54M, an increase of 152.86%. That is a compound annual growth rate of 168.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 806.81M | 13.66% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 784.76M |
| MannKind | 770.25M |
| Kura Oncology | 760.52M |
| Maravai LifeSciences Holdings | 758.35M |
| Tenax Therapeutics | 755.26M |
| SpyGlass Pharma | 750.76M |
| MeiraGTx Holdings | 747.68M |
| SELLAS Life Sciences Group | 741.68M |